Broadcom vs Veeva

New Router Vulnerability 'WPSplinter' Affects Millions of Devices

A Belgian security researcher has uncovered a critical vulnerability in Broadcom's Wi-Fi implementation, dubbed 'WPSplinter'. The flaw, which is actually two separate bugs, allows attackers within Wi-Fi range to execute arbitrary code on affected routers via a crafted WPS message. Broadcom has stated the issue was known since 2010 and was supposedly fixed in 2018, but the patch was insufficient. The vulnerability potentially affects millions of devices from numerous router manufacturers that use Broadcom's Wi-Fi software. The researcher has published a list of affected devices on GitHub and has contacted Broadcom and Belgian authorities. No responses have been received yet, and no public fix is currently available.

• Security researcher Quentin Kaiser discovered the 'WPSplinter' vulnerability in Broadcom's Wi-Fi implementation.
• The vulnerability affects potentially millions of Broadcom-based access points and hundreds of products.
• The flaw has been present since 2010; a 2018 fix was insufficient.

AI Stocks Plunge, Inflation Heats Up, Yet Opportunities Remain

The article discusses last week's stock market decline driven by AI stocks and hotter-than-expected inflation data. The Nasdaq fell 4.5%, while the S&P 500 dropped 2%. However, solid bank earnings and a rotation into defensive sectors provided some optimism. AI-related stocks, particularly memory chip makers and neocloud providers like CoreWeave, experienced significant losses. Meta and Microsoft showed resilience, with Meta releasing new AI models and Microsoft reaching a record high. The article also highlights the importance of diversification and mentions portfolio adjustments, such as adding to Kimberly-Clark and trimming Cardinal Health.

• The Nasdaq fell 4.5% last week, its worst weekly decline since June.
• September CPI rose 3.7% year-over-year, above the expected 3.6%.
• CoreWeave's total debt has risen to over $51 billion, with its stock plunging 25% last week.

Stocks with best risk-adjusted upside on Wall Street

CNBC Pro screened the S&P 500 for stocks with the highest prospective risk-adjusted returns, based on Wall Street analysts' price targets and options-implied volatility over the next 12 months. The list includes tech darlings like Nvidia and Broadcom, as well as Boeing and T-Mobile, along with lesser-known names. The screen was inspired partly by a Goldman Sachs strategy comparing potential excess return on a stock's consensus price target with its implied volatility. Wynn Resorts tops the screen with analysts expecting ~70% upside. T-Mobile ranks near the top with ~54% upside. Micron Technology has nearly 70% upside. Nvidia has over 40% upside. Other names include Oracle, Western Digital, and AppLovin.

• Wynn Resorts tops the screen with analysts expecting about 70% upside.
• T-Mobile shares have dropped nearly 16% over the past month, but analysts see roughly 54% upside.
• Micron Technology analysts forecast nearly 70% upside to consensus price target.

IQVIA Expands Veeva Partnership with Clinical Operations Applications

IQVIA and Veeva Systems announced an expansion of their partnership, with IQVIA selecting Veeva CTMS, eTMF, Study Startup, and Site Connect as enterprise standard applications for its clinical development studies. This extends the previously announced EDC partnership. The collaboration aims to increase trial speed and efficiency, strengthen site centricity, and improve decision-making for clinical research customers. All Veeva clinical solutions will also be available through IQVIA for sponsors seeking a full Veeva technology stack. Executives from both companies emphasized the benefits of integrated technologies and customer flexibility in choosing EDC, RTSM, and eCOA solutions. The announcement was made on October 13, 2026, ahead of the Veeva R&D and Quality Summit scheduled for October 20-21 in Boston.

• IQVIA selected Veeva CTMS, eTMF, Study Startup, and Site Connect as enterprise standard applications.
• Partnership expansion extends the previously announced EDC partnership.
• All Veeva clinical solutions will be available through IQVIA for sponsors.

Servier Adopts Veeva OpenData Globally for AI

Servier, a French pharmaceutical company, is standardizing its customer reference data across more than 80 countries with Veeva OpenData, part of Veeva Data Cloud. This initiative builds on Servier's use of Veeva Link Key People and aims to create an AI-ready data foundation by harmonizing fragmented data silos. The centralized data will help commercial and medical teams gain faster insights and improve efficiency. Liam Hanrahan, Director of Global Operations Excellence at Servier, highlighted that the centralized data will improve processes and enable a semantic layer for better engagement with key healthcare professionals. Veeva's president, Kilian Weiss, emphasized that 89% of AI initiatives fail due to data challenges, and Servier's data-first approach demonstrates industry leadership. The adoption replaces fragmented silos and ensures consistency for scaling advanced analytics and AI.

• Servier standardizes customer reference data with Veeva OpenData across more than 80 countries.
• The initiative builds on Servier's use of Veeva Link Key People.
• Veeva OpenData is part of Veeva Data Cloud, which also includes Veeva Link and Veeva Compass.

New Veeva Study Builder Agent to Configure Clinical Studies in as Little as One Day

Veeva announces a new Study Builder Agent that can configure clinical studies in as little as one day, along with other updates including another Top 20 biopharma choosing Vault CRM and the introduction of Falcon Router for agentic triage.